(Reuters Health) – People with obesity who undergo bariatric surgery have a higher risk of gastroesophageal reflux disease (GERD) with sleeve gastrectomy than with Roux-en-Y gastric bypass, a randomized controlled trial found. Researchers randomized patients with severe obesity and type 2 diabetes to undergo either sleeve gastrectomy (n=55) or Roux-en-Y gastric bypass (n=54). At baseline,
Patients with obesity who had bariatric surgery had a lower risk of having a major adverse cardiovascular event (MACE) or dying from all causes during a median 7-year follow-up, compared with similar patients who did not undergo surgery. These findings, from a province-wide retrospective cohort study from Quebec, follow two recent, slightly shorter similar trials.
Dr Maria S. Altieri There is a need to update the current criteria for the bariatric/metabolic surgery indication to include patients with a body mass index (BMI) of 30 to 35 kg/m2 (class 1 obesity), says the lead author of a new study. The research showed that “bariatric surgery is effective in weight loss and
We and our partners use cookies on this site to improve our service, perform analytics, personalize advertising, measure advertising performance, and remember website preferences.Ok